susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing
Background
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20001016 |
Background
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20001016 |